We are proud to present groundbreaking data at the 5th Swedish Diabetes Summit, revealing a novel approach to treating type 2 diabetes through VDAC1 oligomerization inhibitors. We share our exciting poster presented by our Principal Scientist Ruchi Jain and our Founder, Professor Claes Wollheim at Diabetes.
(Click on the poster to enlarge.)
Recent Comments